IAM Magazine issue 49
September/October 2011Another British piñata
UK revelations centred on one of its tabloid newspapers have left News Corporation, the world’s second biggest media conglomerate, in the eye of a global storm. Once again, a major company is paying the price for not following the rules of effective reputation managementNir Kossovsky and Jonathan Baskin
Features
Trends in US patent litigation
The electronics industry has been at
the heart of the explosion in US
patent suits over the past 20 years. It is important not to forget that –
before coming to conclusions about
overall filing, litigation and licensing
activity
Terry Ludlow
Taking the bay
The fourth IP Business Congress took place at the Palace Hotel in San Francisco from 19th to 21st June. It was attended by more than 500 delegates. Over the three days of the event, they heard a multi-disciplinary speaking faculty of IP thought leaders debate a range of subjects centred on the theme of IP value creation
IP P&L
Is becoming a profit centre and
measuring success something that
all IP departments should aim for?
The answer is not as straightforward as it might perhaps appear at first glance
Sara-Jayne Clover
One-Blue: a blueprint for patent pools in high-tech
With the creation of One-Blue, six companies have developed an
innovative patent pool for Blu-ray
Disc products that levels the playing
field, reduces costs and fosters fair
use of the patent system in the
optical disc sector
Ruud J Peters
Updating IP reporting practices
The way that companies report their
IP activities both internally and
externally is dependent on the
outcomes they are seeking to achieve
Patrick Sullivan and Rupert Mayer
Patent transactions in transition
As the way in which patents are
viewed and exploited by their
owners and third parties has
changed over recent years, so new
ways of defining IP performance
have emerged. The challenge for
corporate IP managers is to keep
up with developments in order to
maximise transaction value
Joseph Sommer
The role of valuation in IP management
Corporate IP managers share their
perspectives on differences in
processes and structures to tackle
IP valuations, a topic that is under
much scrutiny and debate
Lydia Steck and Linda Corcoran
Taking risks
The results of an IP risk survey
undertaken earlier this year among
European and US corporations
show that while IP is increasingly
understood to be an important
corporate asset, IP-related
insurance is yet to be viewed as a
priority
Matthew R Hogg and John Wawrose
Insights
After its Nortel defeat, Google has no option but to look elsewhere
Losing out in the US$4.5 billion Nortel patent auction was undoubtedly a major setback for Google. The company must now spend the money it saved on building a dynamic and strong portfolio that can protect the Android platform. The good news is that it can be done. The bad news is that cash-rich Apple will seek to make it as hard as possible
Seen and heard
A round-up of IP-related quotes, observations and opinions from the recent past ...
Inside the Nortel auction
In addition to Google (operating under the Ranger moniker during the sale process), four parties took part in the auction for the Nortel patent portfolio: Apple; Rockstar Bidco, a consortium of major technology companies consisting of Microsoft, EMC, Sony, Ericsson and RIM; Intel Corporation; and Norpax LLC, an offshoot of RPX Corp.
Columns
Model behaviour
Diverse businesses have made
monetising patents more lucrative and
less painful. They have come a long way,
but are yet to be fully understood
Bruce Berman
The US Supreme Court says “no” to a new invalidity standard
Patent holders can breathe a little more
easily following the US Supreme Court’s
ecent decision in i4i v Microsoft, which
maintains the established burden of proof
necessary to invalidate a patent
Douglas Cawley
Co-published editorialRoundtable
Finding a way through the EU patent litigation maze
Europe may claim to be a single market, but when it comes to patent litigation, this is certainly not the case. Five experts discuss the challenges that this fragmented reality presents
Co-published editorialIndustry insight
Pharmaceutical branding: engineering the perfect name
With more hurdles than ever standing between drug R&D and brand marketing, Jeroen Lallemand of Thomson CompuMark explains how industry best practices are evolving to help create safer trade names more efficiently